3.66
1.39%
0.05
アフターアワーズ:
3.57
-0.09
-2.46%
Pyxis Oncology Inc (PYXS) 最新ニュース
Earth Science Tech (OTCMKTS:ETST) vs. Pyxis Oncology (NASDAQ:PYXS) Head-To-Head Comparison - Defense World
Moment Of Truth Approaches For Pyxis Oncology (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology : Morgan Stanley 22nd Annual Global Healthcare Conference - Marketscreener.com
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - SETE News
Have you been able to find a good deal on Pyxis Oncology Inc’s shares? - US Post News
Quarterly Snapshot: Quick and Current Ratios for Pyxis Oncology Inc (PYXS) - The Dwinnex
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - StockTitan
JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com
PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 - MSN
Market Momentum Report: Pyxis Oncology Inc (PYXS)’s Positive Close at 3.62 - The Dwinnex
Q3 2024 EPS Estimates for Pyxis Oncology, Inc. Boosted by William Blair (NASDAQ:PYXS) - MarketBeat
What is the investor’s view on Pyxis Oncology Inc (PYXS)? - US Post News
Cetera Advisors LLC Makes New $100,000 Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Q3 2024 Earnings Estimate for Pyxis Oncology, Inc. (NASDAQ:PYXS) Issued By William Blair - Defense World
Vanguard Group Inc. Acquires 94,740 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology's (PYXS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com India
Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com
Market Insight: Pyxis Oncology Inc (PYXS)’s Notable Gain, Closing at 3.43 - The Dwinnex
Pyxis Oncology (NASDAQ:PYXS) Earns “Buy” Rating from HC Wainwright - Defense World
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - GlobeNewswire
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - Marketscreener.com
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - StockTitan
Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00 - MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Pyxis Oncology stock gains as Stifel says buy (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat
What was Pyxis Oncology Inc (PYXS)’s performance in the last session? - US Post News
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - Defense World
Stifel sets $10 target on Pyxis Oncology, cites unique approach - Investing.com
Market Recap Check: Pyxis Oncology Inc (PYXS)’s Positive Finish at 3.37, Up/Down 3.69 - The Dwinnex
Pyxis Oncology Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$203m - Simply Wall St
Pyxis Oncology Inc (PYXS) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
SG Americas Securities LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - Marketscreener.com
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - StockTitan
July Breakout: Healthcare Biotechs In The Strongest Move Since November - Seeking Alpha
Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update - MarketBeat
RBC Capital remains positive on Pyxis Oncology stock - Investing.com
Is Pyxis Oncology Inc (PYXS) positioned for future growth? - SETE News
Was Pyxis Oncology Inc (PYXS)’s session last reading good? - US Post News
Pyxis Oncology Inc (PYXS) Stock: A Year of Market Fluctuations - The InvestChronicle
Pyxis Oncology Inc (PYXS) stock analysis: A comprehensive overview - US Post News
Susquehanna Fundamental Investments LLC Invests $351,000 in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.80 Consensus Price Target from Analysts - MarketBeat
Did Pyxis Oncology Inc (PYXS) perform well in the last session? - US Post News
Analytical Overview: Pyxis Oncology Inc (PYXS)’s Ratios Tell a Financial Story - The Dwinnex
Nothing is Better Than Pyxis Oncology Inc (PYXS) stock at the moment - SETE News
Pyxis Oncology Inc (PYXS Stock: A Sea of Opportunity - The InvestChronicle
Pyxis Oncology Inc (PYXS) can make a big difference with a little luck - SETE News
A stock that deserves closer examination: Pyxis Oncology Inc (PYXS) – US Post News - US Post News
Market Momentum Report: Pyxis Oncology Inc (PYXS)'s Positive Close at 3.31 – DWinneX - The Dwinnex
A Pyxis Oncology, Inc. (NASDAQ:PYXS) insider increased their holdings last year - Yahoo Canada Sports
Pyxis Oncology reports inducement grants under Nasdaq listing rule - Medical Buyer
大文字化:
|
ボリューム (24 時間):